These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3264422)

  • 1. [Fenibut treatment of a vascular lesion of the vestibular analyzer].
    Gorokhov EA; Mokrousova TN; Selivanova IG; Skoromets AA; Uriupova GN
    Sov Med; 1988; (8):90-2. PubMed ID: 3264422
    [No Abstract]   [Full Text] [Related]  

  • 2. [Surheme in the treatment of cochleo-vestibular syndromes of vascular origin].
    Meunier JL; Forestier R
    Ann Otolaryngol Chir Cervicofac; 1973 Jun; 90(6):397-407. PubMed ID: 4541765
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy of non-inflammatory vestibular syndromes].
    Sirjiţă N
    Otorinolaringologie; 1972; 17(3):197-204. PubMed ID: 4402273
    [No Abstract]   [Full Text] [Related]  

  • 4. Perspectives on the pharmacotherapy of vertigo.
    Zee DS
    Arch Otolaryngol; 1985 Sep; 111(9):609-12. PubMed ID: 3875336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug therapy of peripheral vestibular vertigo--effects of Duvadilan in double blind test].
    Goto K; Okutomi A; Utsunomiya M; Takahashi F
    Jibiinkoka; 1971 May; 43(5):405-11. PubMed ID: 4939297
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences with betahistine].
    Müller H; Buttkus R
    Laryngol Rhinol Otol (Stuttg); 1983 Apr; 62(4):151-3. PubMed ID: 6602925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ischemia of the anterior vestibular artery (Lindsay-Hemenway syndrome). Review and comments].
    Pardal Refoyo JL; Pérez Plasencia D; Beltrán Mateos LD
    Acta Otorrinolaringol Esp; 1998; 49(8):599-602. PubMed ID: 9951076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of Betaserc in auditory and vestibular disturbances.
    Petrova D; Sachansca T; Datcov E
    Int Tinnitus J; 2004; 10(2):177-82. PubMed ID: 15732519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Principles of conservative therapy of peripheral and central disorders of equilibrium].
    Ehrenberger K
    HNO; 1988 Aug; 36(8):301-4. PubMed ID: 3049473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new treatment of vertigo by cerebral microcirculation regulation and oxygenator action on the sensorial epithelium of vestibule].
    Ardouin P
    Rev Laryngol Otol Rhinol (Bord); 1971; 92(9):585-92. PubMed ID: 4946050
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylprednisolone for status migrainous vertigo and cephalic status migrainosus.
    Robbins MS; Wang D; DeOrchis VS
    Headache; 2010 Feb; 50(2):328. PubMed ID: 20456136
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological considerations on drugs used in non-inflammatory vestibular syndromes].
    Manolescu E
    Otorinolaringologie; 1972; 17(3):205-9. PubMed ID: 4402274
    [No Abstract]   [Full Text] [Related]  

  • 13. Flunarizine and cinnarizine as vestibular depressants. A statistical study.
    Mangabeira-Albernaz PL; Ganança MM; Novo NF; de Paiva ER
    ORL J Otorhinolaryngol Relat Spec; 1978; 40(2):92-100. PubMed ID: 311458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of Meniere's disease and otogenic vestibular disorders by means of intravenous injection of sodium hydrocarbonate].
    Potapov II; Volkov IuN; Barnatskiĭ VN; Kuznetsov AG; Balshaĭte IaV
    Vestn Otorinolaringol; 1971; 33(3):40-4. PubMed ID: 5315393
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute loss of vestibular function: an emergency for patient and physician].
    Streinzer W; Zrunek M; Fürpass E
    Wien Klin Wochenschr; 1986 Jun; 98(13):421-5. PubMed ID: 3489323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aetiology and management of vertigo (author's transl)].
    Beck C
    HNO; 1979 Aug; 27(8):253-5. PubMed ID: 391783
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of glucuronyl glucosamine glycan sulfate in dyslipidemic subjects with labyrinth disease].
    Serra A; Vancheri M; Di Mauro A
    G Clin Med; 1980 Dec; 61(12):919-27. PubMed ID: 7215740
    [No Abstract]   [Full Text] [Related]  

  • 18. Betahistine treatment in managing vertigo and improving vestibular compensation: clarification.
    Lacour M
    J Vestib Res; 2013; 23(3):139-51. PubMed ID: 24177346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electronystagmographic and caloric investigation data about vascular-vestibular dysfunction among patients with vertebrobasilar insufficiency.
    Petrova D; Hannig A
    Int Tinnitus J; 2003; 9(1):48-51. PubMed ID: 14763330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The vascular factor in vertigo].
    Bucur A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1986; 31(1):51-63. PubMed ID: 2942973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.